Coronary Artery Disease (CAD) and Angina and Ranolazine (Ranexa)
Ranolazine (Ranexa) is an anti-anginal medication that does not depend on reductions in heart rate or blood pressure. It reduces the frequency of anginal chest pain, but has not been shown to reduce heart attacks.
Effect of Ranolazine (Ranexa) on Coronary Artery Disease (CAD) and Angina
Ranolazine reduces angina by improving blood flow, helping the heart work more efficiently.
Side Effects and Warnings
Possible side effects of ranolazine include:
- Changes in electrocardiogram readings
- Potential to interact with other medications—This medication should be avoided in patients with liver or severe kidney disease.